Dyadic empowerment program for managing heart failure
The Effects and Cost-effectiveness of a Dyadic Empowerment-based Heart Failure Management Program (De-HF) on Self-care, HRQL and Hospital Readmission: A Randomized Controlled Trial
NA · The University of Hong Kong · NCT05806606
This study is testing a new program that helps heart failure patients and their caregivers work together better to manage the condition and see if it can improve their health and reduce hospital visits.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 232 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | The University of Hong Kong (other) |
| Locations | 1 site (Hong Kong) |
| Trial ID | NCT05806606 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates a Dyadic Empowerment-based Heart Failure Management Program aimed at improving self-care and health outcomes for heart failure patients and their primary caregivers. The program includes a series of educational modules designed to enhance collaboration between patients and caregivers in managing heart failure. Participants will be recruited from three regional hospitals in Hong Kong, and the study will assess the program's effectiveness in reducing hospital readmissions and improving quality of life. The intervention consists of home visits and online sessions over a 16-week period.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 or older with a confirmed diagnosis of heart failure and a primary caregiver living with them.
Not a fit: Patients who do not live with a primary caregiver or have end-stage renal disease requiring hemodialysis may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly enhance self-care practices and reduce hospitalizations for heart failure patients.
How similar studies have performed: Previous studies have shown that dyadic approaches can improve health outcomes in chronic disease management, suggesting potential success for this program.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 18 or above * Confirmed medical diagnosis of Heart Failure by a cardiologist of at least 3 months * New York Heart Association (NYHA) Class II-IV symptoms * Discharged home after an admission to the recruitment setting * Carer co-residing with the patients in the same household * Carer self-identified as the primary carer for the patients * Both the patient and the carer having adequate cognitive ability (as indicated by an Abbreviated Test Score of \>6) * Have at least one Smartphone or device to access the online meetings and videos Exclusion Criteria: * Not living with primary caregiver * With end-stage renal disease relying on hemodialysis rather than HF medications to regulate fluid volume.
Where this trial is running
Hong Kong
- Department of Medicine, Tseung Kwan O Hospital — Hong Kong, Hong Kong (RECRUITING)
Study contacts
- Principal investigator: Doris Sau Fung YU, PhD — The University of Hong Kong
- Study coordinator: Doris Sau Fung YU, PhD
- Email: dyu1@hku.hk
- Phone: 39176319
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Heart Failure, Self Care, Empowerment, Transitional Care, Disease Management, Dyadic, Disease management, Transitional care